Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals
Chronic hepatitis C virus (HCV) infection is associated with an increased risk of extrahepatic cancers, particularly non-Hodgkin lymphoma.The introduction of direct-acting antivirals (DAAs) has revolutionized HCV therapy, resulting in high cure rates.However, concerns have been raised about potential effects on cancer risk.This review summarizes th